Literature DB >> 18854744

Uric acid: bystander or culprit in hypertension and progressive renal disease?

Paolo Menè1, Giorgio Punzo.   

Abstract

In humans, uric acid is the main urinary metabolite of purines. Serum levels are higher compared with other mammalians. Uric acid is an antioxidant and perhaps helps to control blood pressure during a low Na+ diet through stimulation of the renin-angiotensin system. Serum uric acid is also considered a marker of tubular reabsorption and 'effective' circulating blood volume. Moreover, hyperuricemia seems to be a cofactor in Na+ -sensitive hypertension, a marker and possibly itself responsible for microvascular damage through stimulation of the renin-angiotensin system, inhibition of endothelial nitric oxide, and proliferative effects on vascular smooth muscle. As fructose-rich diets increase uric acid levels, hyperuricemia may also play a role in the metabolic syndrome, triggering insulin resistance and hypertension.A number of studies on rats rendered hyperuricemic by administration of uricase inhibitors have recently confirmed induction of arterial hypertension and microvascular injury, particularly in the remnant kidney or in cyclosporine-induced renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854744     DOI: 10.1097/HJH.0b013e32830e4945

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  34 in total

1.  Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study.

Authors:  V Saroja Voruganti; Sandra Laston; Karin Haack; Nitesh R Mehta; Shelley A Cole; Nancy F Butte; Anthony G Comuzzie
Journal:  Am J Clin Nutr       Date:  2015-01-28       Impact factor: 7.045

2.  Facilitative glucose transporter 9, a unique hexose and urate transporter.

Authors:  Manuel Doblado; Kelle H Moley
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10       Impact factor: 4.310

3.  Putative Role of Cardio Metabolic Risk Among Poorly Controlled Asthmatics in South Indian Population.

Authors:  Murugaiyan Sathish Babu; K P Sreesoorya; Surendra K Menon; Subiman Saha; A R Srinivasan; S Arul Vijaya Vani; R Reeta; V Kuzhandai Velu
Journal:  Indian J Clin Biochem       Date:  2016-07-22

4.  Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.

Authors:  May A Beydoun; Jose-Atilio Canas; Gregory A Dore; Hind A Beydoun; Ola S Rostant; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  J Alzheimers Dis       Date:  2016-04-21       Impact factor: 4.472

5.  Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study.

Authors:  Andrea Semplicini
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-23

6.  Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis.

Authors:  Walter Ludwig Strohmaier; Beate Maria Wrobel; Gernot Schubert
Journal:  Urol Res       Date:  2011-08-25

7.  Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study.

Authors:  Evagelia C Laiakis; Gerard A J Morris; Albert J Fornace; Stephen R C Howie
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

8.  Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.

Authors:  Severin Kengne-Wafo; Laura Massella; Francesca Diomedi-Camassei; Alessandra Gianviti; Marina Vivarelli; Marcella Greco; Gilda Rita Stringini; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 8.237

9.  Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.

Authors:  Frédéric Preitner; Olivier Bonny; Alexandra Laverrière; Samuel Rotman; Dmitri Firsov; Anabela Da Costa; Salima Metref; Bernard Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-21       Impact factor: 11.205

Review 10.  Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.

Authors:  Claudio Borghi; Alberto Palazzuoli; Matteo Landolfo; Eugenio Cosentino
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.